ITM-63

N/A

Report date: 2025/11/24 17:31:46

Base Information

Drug NameITM-63

Drug Alias NameTb161-labelled radiopharmaceutical theranosticITM-63

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionIonising radiation emittersRadionuclide imaging enhancersSomatostatin receptor modulators

TargetsSomatostatin receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesItm Solucin Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesItm Solucin Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A